Skip to content
10-Q

Quarterly Report

HUAIZHONG HEALTH GROUP INC.

0001640334-21-001342

← back to feed
Filed
Jun 14, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jun 11, 2021 31.52M sh
Cash And Equivalents Q2 2021 · Apr 30, 2021 $0
Cash And Equivalents Q2 2021 · Oct 31, 2020 $0
Cash And Equivalents Q2 2021 · Apr 30, 2020 $0
Cash And Equivalents Q2 2021 · Oct 31, 2019 $0
Current Liabilities Q2 2021 · Apr 30, 2021 $43.02K
Current Liabilities Q2 2021 · Oct 31, 2020 $19.47K
Total Liabilities Q2 2021 · Apr 30, 2021 $43.02K
Total Liabilities Q2 2021 · Oct 31, 2020 $19.47K
Current Assets Q2 2021 · Apr 30, 2021 $0
Current Assets Q2 2021 · Oct 31, 2020 $0
Total Assets Q2 2021 · Apr 30, 2021 $0
Total Assets Q2 2021 · Oct 31, 2020 $0
Operating Cash Flow restated Q2 2021 · Apr 30, 2020 $0
Stockholders Equity Q2 2021 · Apr 30, 2020 −$32.99K
Stockholders Equity Q2 2021 · Jan 31, 2020 −$26.53K
Stockholders Equity Q2 2021 · Oct 31, 2019 −$21.1K
Sga Expense Q2 2021 · Apr 30, 2020 $6.3K
Sga Expense Q2 2021 · Apr 30, 2020 $11.62K
Net Income Q2 2021 · Apr 30, 2020 −$6.46K
Net Income Q2 2021 · Apr 30, 2020 −$11.89K
Net Income Q2 2021 · Jan 31, 2020 −$5.43K
Operating Income Q2 2021 · Apr 30, 2020 −$6.3K
Operating Income Q2 2021 · Apr 30, 2020 −$11.62K
Revenue Q2 2021 · Apr 30, 2020 $0
Revenue Q2 2021 · Apr 30, 2020 $0